Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
13 July 2023 | Story Andre Damons | Photo Samkelo Fetile
Prof Catherine Comiskey
Prof Catherine Comiskey, a professor in Healthcare Statistics from the School of Nursing and Midwifery at Trinity College Dublin and Academic Director of CHARM-EU, presents a lecture on building a research career with global impact to members of the UFS Transformation of the Professoriate Mentoring Programme.

A visiting scholar from Trinity College Dublin in Ireland visited the University of the Free State (UFS) to work with staff members from the UFS Transformation of the Professoriate Mentoring Programme on identifying collaborations, writing, and building a research career.

Prof Catherine Comiskey, a professor in Healthcare Statistics from the School of Nursing and Midwifery at Trinity College Dublin and Academic Director of CHARM-EU – an EU-funded academic programme – held a writing retreat for participants in the Transformation of the Professoriate Mentoring Programme in the last week of June. She also worked with individual members to identify potential European and UK collaborators on various research projects. On Friday 30 June, she presented a lecture on building a research career with global impact.

Encouraging staff members

According to Dr Henriëtte van den Berg, Manager: Transformation of the Professoriate Mentoring Programme, Prof Comiskey encouraged colleagues to develop a research and publication strategy to ensure that they optimise the work they are doing, to look for opportunities to collaborate with colleagues across different disciplines, and to work together on publications and the supervision of postgraduate students.

“She also emphasised the importance of collaborating with people in industry, as they often have a rich source of data that is publishable. She highlighted the importance of being an ethical researcher. The workshop participants benefited from her passion and broad knowledge to start planning collaborations and to reflect on how they can make the work they are already doing work more for them. A group of workshop participants has already started working on a systematic review that they will conduct in collaboration with Prof Comiskey,” said Dr Van den Berg.

Share expertise

Prof Comiskey facilitated online writing interventions for the colleagues of the mentoring programme during COVID-19 lockdown restrictions. She was invited to the campus to share her expertise in quantitative methodology and transdisciplinary work.

Prof Comiskey completed a PhD in Mathematics and coordinates many interdisciplinary research teams, comprising applied mathematicians, statisticians, psychologists, medical doctors, sociologists, anthropologists, nurses, computer scientists, and healthcare employees. She has been selected as one of five international experts nominated by the European Commission to serve on the International Scientific Committee of the European Monitoring Centre for Drugs and Drug Addiction.

She has 30 years’ experience of teaching, research, postgraduate supervision, and teaching to specialists and non-specialists in all areas of applied statistics, mathematics, and epidemiology. She is also a seasoned academic leader, having served as Research Director at Trinity College, Dublin for many years.

CHARM-EU is an EU-funded academic programme spanning five European universities to develop, run, and evaluate a new EU-wide model for Universities of the Future. This involves a new transdisciplinary master’s degree that addresses the Sustainable Development Goals (SDG).  

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept